Author:
Minguet Joan,Smith Katherine H.,Bramlage Carsten P.,Bramlage Peter
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference96 articles.
1. IARC (2012) GLOBOCAN estimated cancer incidence, mortality and prevalence worldwide. WHO. http://globocan.iarc.fr/ . Accessed Dec 2014
2. Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353(23):2477–2490. doi: 10.1056/NEJMra043172
3. Amato RJ (2000) Chemotherapy for renal cell carcinoma. Semin Oncol 27(2):177–186
4. Mattei J, da Silva RD, Sehrt D, Molina WR, Kim FJ (2014) Targeted therapy in metastatic renal carcinoma. Cancer Lett 343(2):156–160. doi: 10.1016/j.canlet.2013.09.038
5. Negrier S, Escudier B, Lasset C, Douillard JY, Savary J, Chevreau C, Ravaud A, Mercatello A, Peny J, Mousseau M, Philip T, Tursz T (1998) Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d’Immunotherapie. N Engl J Med 338(18):1272–1278. doi: 10.1056/nejm199804303381805
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献